Trust Point’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$644K Buy
7,466
+1,755
+31% +$155K 0.05% 207
2026
Q2
$447K Sell
5,711
-2,438
-30% -$197K 0.04% 247
2026
Q1
$706K Sell
8,149
-534
-6% -$51.2K 0.06% 172
2025
Q4
$834K Sell
8,683
-381
-4% -$37K 0.07% 146
2025
Q3
$863K Sell
9,064
-3,144
-26% -$289K 0.07% 139
2025
Q2
$1.06M Buy
12,208
+3,041
+33% +$258K 0.1% 104
2025
Q1
$824K Sell
9,167
-2,638
-22% -$236K 0.08% 135
2024
Q4
$943K Buy
11,805
+693
+6% +$60K 0.07% 170
2024
Q3
$1M Sell
11,112
-398
-3% -$33.5K 0.08% 165
2024
Q2
$906K Sell
11,510
-358
-3% -$29.3K 0.07% 166
2024
Q1
$1.03M Buy
11,868
+1,313
+12% +$112K 0.08% 154
2023
Q4
$870K Buy
+10,555
New +$804K 0.07% 158

Other funds holding MDT

Trust Point's MDT Position: Q3 2026 in Review

Trust Point increased its Medtronic (MDT) stake by 31% in Q3 2026, buying an estimated $155K and bringing the position to 7,466 shares worth $644K. The position accounts for 0.05% of the portfolio, ranked #207.

Trust Point first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.06M in Q2 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Trust Point held 7,466 shares of Medtronic worth $644K as of Q3 2026.
  • Trust Point bought 1,755 Medtronic shares in Q3 2026, an estimated $155K.
  • Medtronic made up 0.05% of Trust Point's portfolio in Q3 2026, its #207 holding.
  • Trust Point first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Medtronic position peaked at $1.06M in Q2 2025.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.